Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 154537, 9 pages
http://dx.doi.org/10.1155/2013/154537
Review Article

Residual Renal Function in Children Treated with Chronic Peritoneal Dialysis

Department of Pediatrics and Nephrology, Medical University of Warsaw, 24 Marszalkowska Street, 00-576 Warsaw, Poland

Received 11 September 2013; Accepted 20 October 2013

Academic Editors: J. C. K. Leung and G. Montini

Copyright © 2013 Maria Roszkowska-Blaim and Piotr Skrzypczyk. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “NKF KDOQI 2006 updates clinical practice guidelines and clinical practice recommendations for hemodialysis adequacy, peritoneal dialysis adequacy and vascular access,” The American Journal of Kidney Diseases, vol. 48, supplement 1, pp. 1–322, 2006.
  2. S. M. Chandna and K. Farrington, “Residual renal function: considerations on its importance and preservation in dialysis patients,” Seminars in Dialysis, vol. 17, no. 3, pp. 196–201, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Feber, K. Scharer, F. Schaefer, M. Mikova, and J. Janda, “Residual renal function in children on haemodialysis and peritoneal dialysis therapy,” Pediatric Nephrology, vol. 8, no. 5, pp. 579–583, 1994. View at Google Scholar · View at Scopus
  4. M. Fischbach, J. Terzic, S. Menouer et al., “Effects of automated peritoneal dialysis on residual daily urinary volume in children,” Advances in Peritoneal Dialysis, vol. 17, pp. 269–273, 2001. View at Google Scholar · View at Scopus
  5. G. J. Schwartz, G. B. Haycock, C. M. Edelmann Jr., and A. Spitzer, “A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine,” Pediatrics, vol. 58, no. 2, pp. 259–263, 1976. View at Google Scholar · View at Scopus
  6. R. Counahan, C. Chantler, S. Ghazali, B. Kirkwood, F. Rose, and T. M. Barratt, “Estimation of glomerular filtration rate from plasma creatinine concentration in children,” Archives of Disease in Childhood, vol. 51, no. 11, pp. 875–878, 1976. View at Google Scholar · View at Scopus
  7. A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, and D. Roth, “A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation,” Annals of Internal Medicine, vol. 130, no. 6, pp. 461–470, 1999. View at Google Scholar · View at Scopus
  8. D. W. Cockcroft and M. H. Gault, “Prediction of creatinine clearance from serum creatinine,” Nephron, vol. 16, no. 1, pp. 31–41, 1976. View at Google Scholar · View at Scopus
  9. S. J. Kim, Y. B. Sohn, S. W. Park, D. K. Jin, and K. H. Paik, “Serum cystatin C for estimation of residual renal function in children on peritoneal dialysis,” Pediatric Nephrology, vol. 26, no. 3, pp. 433–440, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. K. Swan, C. E. Halstenson, B. L. Kasiske, and A. J. Collins, “Determination of residual renal function with iohexol clearance in hemodialysis patients,” Kidney International, vol. 49, no. 1, pp. 232–235, 1996. View at Google Scholar · View at Scopus
  11. K. D. Kjaergaard, J. D. Jensen, B. Jespersen, and M. Rehling, “Reliability of51Cr-EDTA plasma and urinary clearance as a measure of residual renal function in dialysis patients,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 71, no. 8, pp. 663–669, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Burkart and J. M. Bargman, “Adequacy of peritoneal dialysis, including fluid balance,” in Nolph and Gokal's Textbook of Peritoneal Dialysis, R. Khanna and R. T. Krediet, Eds., pp. 469–504, Springer, New York, NY, USA, 3rd edition, 2009. View at Google Scholar
  13. B. A. Warady, S. R. Alexander, and F. Schaefer, “Peritoneal dialysis in children,” in Nolph and Gokal's Textbook of Peritoneal Dialysis, R. Khanna and R. T. Krediet, Eds., pp. 803–860, Springer, New York, NY, USA, 3rd edition, 2009. View at Google Scholar
  14. “NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy,” The American Journal of Kidney Diseases, vol. 30, no. 3, supplement 2, pp. 67–136, 1997.
  15. National Kidney Foundation, “K/DOQI clinical practice guidelines for peritoneal dialysis adequacy, 2000,” The American Journal of Kidney Diseases, vol. 37, supplement 1, pp. 65–136, 2001. View at Google Scholar
  16. C. S. Wong, S. Hingorani, D. L. Gillen et al., “Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease,” Kidney International, vol. 61, no. 2, pp. 630–637, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. L. González-Espinoza, J. Gutiérrez-Chávez, F. Martín del Campo et al., “Randomized, open label, controlled clinical trial of oral administration of an egg albumin-based protein supplement to patients on continuous ambulatory peritoneal dialysis,” Peritoneal Dialysis International, vol. 25, no. 2, pp. 173–180, 2005. View at Google Scholar · View at Scopus
  18. R. Paniagua, D. Amato, E. Vonesh et al., “Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial,” Journal of the American Society of Nephrology, vol. 13, no. 5, pp. 1307–1320, 2002. View at Google Scholar · View at Scopus
  19. W. K. Lo, Y. W. Ho, C. S. Li et al., “Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study,” Kidney International, vol. 64, no. 2, pp. 649–656, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. H. H. Chen, A. Shetty, I. E. Afthentopoulos, and D. G. Oreopoulos, “Discrepancy between weekly KT/V and weekly creatinine clearance in patients on CAPD,” Advances in Peritoneal Dialysis, vol. 11, pp. 83–87, 1995. View at Google Scholar · View at Scopus
  21. Z. J. Twardowski, “Relationship between creatinine clearance and Kt/V in peritoneal dialysis: a response to the defense of the DOQI document,” Peritoneal Dialysis International, vol. 19, no. 3, pp. 199–203, 1999. View at Google Scholar · View at Scopus
  22. N. Lameire and W. van Biesen, “The impact of residual renal function on the adequacy of peritoneal dialysis,” Peritoneal Dialysis International, vol. 17, no. supplement 2, pp. S102–S110, 1997. View at Google Scholar · View at Scopus
  23. V. Venkataraman and K. D. Nolph, “Preservation of residual renal function—an important goal,” Peritoneal Dialysis International, vol. 20, no. 4, pp. 392–395, 2000. View at Google Scholar · View at Scopus
  24. W. van Biesen, R. Vanholder, and N. Lameire, “The role of peritoneal dialysis as the first-line renal replacement modality,” Peritoneal Dialysis International, vol. 20, no. 4, pp. 375–383, 2000. View at Google Scholar · View at Scopus
  25. J. Wilson and A. R. Nissenson, “Determinants in APD selection,” Seminars in Dialysis, vol. 15, no. 6, pp. 388–392, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. D. N. Churchill, D. W. Taylor, P. R. Keshaviah, and CANUSA Peritoneal Dialysis Study Group, “Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes,” Journal of the American Society of Nephrology, vol. 7, no. 2, pp. 198–207, 1996. View at Google Scholar · View at Scopus
  27. J. M. Bargman, K. E. Thorpe, D. N. Churchill, and CANUSA Peritoneal Dialysis Study Group, “Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study,” Journal of the American Society of Nephrology, vol. 12, no. 10, pp. 2158–2162, 2001. View at Google Scholar · View at Scopus
  28. F. Termorshuizen, J. C. Korevaar, F. W. Dekker, J. G. van Manen, E. W. Boeschoten, and R. T. Krediet, “The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands cooperative study on the adequacy of dialysis (NECOSAD)-2,” The American Journal of Kidney Diseases, vol. 41, no. 6, pp. 1293–1302, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Bammens, P. Evenepoel, K. Verbeke, and Y. Vanrenterghem, “Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms,” Kidney International, vol. 64, no. 6, pp. 2238–2243, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Amici, G. Virga, G. Da Rin et al., “Serum beta-2-microglobulin level and residual renal function in peritoneal dialysis,” Nephron, vol. 65, no. 3, pp. 469–471, 1993. View at Google Scholar · View at Scopus
  31. D. E. Pagé, G. A. Knoll, and V. Cheung, “The relationship between residual renal function, protein catabolic rate, and phosphate and magnesium levels in peritoneal dialysis patients,” Advances in Peritoneal Dialysis, vol. 18, pp. 189–191, 2002. View at Google Scholar · View at Scopus
  32. R. López-Menchero, A. Miguel, R. García-Ramón, J. Pérez-Contreras, V. Girbés, and A. M. Carrasco, “Importance of residual renal function in continuous ambulatory peritoneal dialysis: its influence on different parameters of renal replacement treatment,” Nephron, vol. 83, no. 3, pp. 219–225, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. E. L. Penne, N. C. van der Weerd, M. P. C. Grooteman et al., “Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 2, pp. 281–289, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Pérez-Flores, F. Coronel, S. Cigarrán, J. A. Herrero, and N. Calvo, “Relationship between residual renal function, inflammation, and anemia in peritoneal dialysis,” Advances in Peritoneal Dialysis, vol. 23, pp. 140–143, 2007. View at Google Scholar · View at Scopus
  35. A. Y. Wang, M. M. Sea, R. Ip et al., “Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis,” Journal of the American Society of Nephrology, vol. 12, no. 11, pp. 2450–2457, 2001. View at Google Scholar · View at Scopus
  36. C. J. A. M. Konings, J. P. Kooman, M. Schonck et al., “Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study,” Nephrology Dialysis Transplantation, vol. 18, no. 4, pp. 797–803, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. M. K. Menon, D. M. Naimark, J. M. Bargman, S. I. Vas, and D. G. Oreopoulos, “Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function,” Nephrology Dialysis Transplantation, vol. 16, no. 11, pp. 2207–2213, 2001. View at Google Scholar · View at Scopus
  38. L. M. Moist, F. K. Port, S. M. Orzol et al., “Predictors of loss of residual renal function among new dialysis patients,” Journal of the American Society of Nephrology, vol. 11, no. 3, pp. 556–564, 2000. View at Google Scholar · View at Scopus
  39. M. Misra, E. Vonesh, J. C. Van Stone, H. L. Moore, B. Prowant, and K. D. Nolph, “Effect of cause and time of dropout on the residual GFR: a comparative analysis of the decline of GFR on dialysis,” Kidney International, vol. 59, no. 2, pp. 754–763, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. S. M. Lang, A. Bergner, M. Töpfer, and H. Schiffl, “Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors,” Peritoneal Dialysis International, vol. 21, no. 1, pp. 52–57, 2001. View at Google Scholar · View at Scopus
  41. M. A. M. Jansen, A. A. M. Hart, J. C. Korevaar, F. W. Dekker, E. W. Boeschoten, and R. T. Krediet, “Predictors of the rate of decline of residual renal function in incident dialysis patients,” Kidney International, vol. 62, no. 3, pp. 1046–1053, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. W. McKane, S. M. Chandna, J. E. Tattersall, R. N. Greenwood, and K. Farrington, “Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD,” Kidney International, vol. 61, no. 1, pp. 256–265, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Hidaka and T. Nakao, “Preservation of residual renal function and factors affecting its decline in patients on peritoneal dialysis,” Nephrology, vol. 8, no. 4, pp. 184–191, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Hufnagel, C. Michel, G. Queffeulou, H. Skhiri, H. Damieri, and F. Mignon, “The influence of automated peritoneal dialysis on the decrease in residual renal function,” Nephrology Dialysis Transplantation, vol. 14, no. 5, pp. 1224–1228, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Hiroshige, K. Yuu, M. Soejima, M. Takasugi, and A. Kuroiwa, “Rapid decline of residual renal function in patients on automated peritoneal dialysis,” Peritoneal Dialysis International, vol. 16, no. 3, pp. 307–315, 1996. View at Google Scholar · View at Scopus
  46. D. W. Johnson, D. W. Mudge, J. M. Sturtevant et al., “Predictors of decline of residual renal function in new peritoneal dialysis patients,” Peritoneal Dialysis International, vol. 23, no. 3, pp. 276–283, 2003. View at Google Scholar · View at Scopus
  47. J. L. Holley, N. Aslam, J. Bernardini, L. Fried, and B. Piraino, “The influence of demographic factors and modality on loss of residual renal function in incident peritoneal dialysis patients,” Peritoneal Dialysis International, vol. 21, no. 3, pp. 302–305, 2001. View at Google Scholar · View at Scopus
  48. S. Bro, J. B. Bjorner, P. Tofte-Jensen et al., “A prospective, randomized multicenter study comparing APD and CAPD treatment,” Peritoneal Dialysis International, vol. 19, no. 6, pp. 526–533, 1999. View at Google Scholar · View at Scopus
  49. C. W. H. de Fijter, L. P. Oe, J. J. P. Nauta et al., “Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis,” Annals of Internal Medicine, vol. 120, no. 4, pp. 264–271, 1994. View at Google Scholar · View at Scopus
  50. H. Iles-Smith, J. Curwell, and R. Gokal, “Comparative evaluation of CAPD and PD-plus effectiveness,” EDTNA-ERCA Journal, vol. 25, no. 3, pp. 27–29, 1999. View at Google Scholar · View at Scopus
  51. K. S. Rabindranath, J. Adams, T. Z. Ali, C. Daly, L. Vale, and A. M. MacLeod, “Automated vs continuous ambulatory peritoneal dialysis: a systematic review of randomized controlled trials,” Nephrology Dialysis Transplantation, vol. 22, no. 10, pp. 2991–2998, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. K. H. Oh, J. Y. Moon, J. Oh et al., “Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients,” Nephrology Dialysis Transplantation, vol. 23, no. 7, pp. 2356–2364, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. C. T. Liao, C. C. Shiao, J. W. Huang et al., “Predictors of faster decline of residual renal function in Taiwanese peritoneal dialysis patients,” Peritoneal Dialysis International, vol. 28, supplement 3, pp. S191–S195, 2008. View at Google Scholar · View at Scopus
  54. M. K. Singhal, S. Bhaskaran, E. Vidgen, J. M. Bargman, S. I. Vas, and D. G. Oreopoulos, “Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it,” Peritoneal Dialysis International, vol. 20, no. 4, pp. 429–438, 2000. View at Google Scholar · View at Scopus
  55. S. K. Shin, H. Noh, S. W. Kang et al., “Risk factors influencing the decline of residual renal function in continuous ambulatory peritoneal dialysis patients,” Peritoneal Dialysis International, vol. 19, no. 2, pp. 138–142, 1999. View at Google Scholar · View at Scopus
  56. M. Haag-Weber, R. Krämer, R. Haake et al., “Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study,” Nephrology Dialysis Transplantation, vol. 25, no. 7, pp. 2288–2296, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Adachi, Y. Nakagawa, and A. Nishio, “Icodextrin preserves residual renal function in patients treated with automated peritoneal dialysis,” Peritoneal Dialysis International, vol. 26, no. 3, pp. 405–407, 2006. View at Google Scholar · View at Scopus
  58. J. F. Medcalf, K. P. G. Harris, and J. Walls, “Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis,” Kidney International, vol. 59, no. 3, pp. 1128–1133, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. I. Kolesnyk, M. Noordzij, F. W. Dekker, E. W. Boeschoten, and R. T. Krediet, “Treatment with angiotensin II inhibitors and residual renal function in peritoneal dialysis patients,” Peritoneal Dialysis International, vol. 31, no. 1, pp. 53–59, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Shemin, D. Maaz, D. St. Pierre, S. I. Kahn, and J. A. Chazan, “Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients,” The American Journal of Kidney Diseases, vol. 34, no. 1, pp. 14–20, 1999. View at Google Scholar · View at Scopus
  61. S. V. Badve, C. M. Hawley, S. P. McDonald et al., “Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function,” Nephrology Dialysis Transplantation, vol. 27, no. 1, pp. 381–387, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. S. L. Lui, S. W. Cheng, F. Ng et al., “Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function,” Kidney International, vol. 68, no. 5, pp. 2375–2380, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. E. Dittrich, H. Puttinger, M. Schillinger et al., “Effect of radio contrast media on residual renal function in peritoneal dialysis patients—a prospective study,” Nephrology Dialysis Transplantation, vol. 21, no. 5, pp. 1334–1339, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. S. H. Kang, K. H. Cho, J. W. Park, K. W. Yoon, and J. Y. Do, “Proteinuria as a risk factor for decline in residual renal function in non-diabetic peritoneal dialysis patients,” Kidney and Blood Pressure Research, vol. 37, no. 2-3, pp. 199–210, 2013. View at Publisher · View at Google Scholar
  65. http://www.espn-reg.org/files/ESPN%20ERAEDTA%20AR2010.pdf.
  66. https://web.emmes.com/study/ped/annlrept/annualrept2011.pdf.
  67. http://www.anzdata.org.au/anzdata/AnzdataReport/35thReport/2012c11_paediatric_v1.9.pdf.
  68. A. Fusshoeller, “Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis,” Pediatric Nephrology, vol. 23, no. 1, pp. 19–25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Sitter and M. Sauter, “Impact of glucose in peritoneal dialysis: saint or sinner?” Peritoneal Dialysis International, vol. 25, no. 5, pp. 415–425, 2005. View at Google Scholar · View at Scopus
  70. J. C. K. Leung, L. Y. Y. Chan, S. C. W. Tang, K. M. Chu, and K. N. Lai, “Leptin induces TGF-β synthesis through functional leptin receptor expressed by human peritoneal mesothelial cell,” Kidney International, vol. 69, no. 11, pp. 2078–2086, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. L. S. Aroeira, A. Aguilera, R. Selgas et al., “Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor,” The American Journal of Kidney Diseases, vol. 46, no. 5, pp. 938–948, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. L. S. Aroeira, A. Aguilera, J. A. Sánchez-Tomero et al., “Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions,” Journal of the American Society of Nephrology, vol. 18, no. 7, pp. 2004–2013, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. W. Smit, N. Schouten, N. van den Berg et al., “Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: a cross-sectional study,” Peritoneal Dialysis International, vol. 24, no. 6, pp. 562–570, 2004. View at Google Scholar · View at Scopus
  74. M. Honda, K. Iitaka, H. Kawaguchi et al., “The Japanese National Registry data on pediatric CAPD patients: a ten-year experience. A report of the study group of pediatric PD conference,” Peritoneal Dialysis International, vol. 16, no. 3, pp. 269–275, 1996. View at Google Scholar · View at Scopus
  75. R. Saxena, “Pathogenesis and treatment of peritoneal membrane failure,” Pediatric Nephrology, vol. 23, no. 5, pp. 695–703, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Hoshii and M. Honda, “High incidence of encapsulating peritoneal sclerosis in pediatric patients on peritoneal dialysis longer than 10 years,” Peritoneal Dialysis International, vol. 22, no. 6, pp. 730–731, 2002. View at Google Scholar · View at Scopus
  77. R. Shroff, C. J. Stefanidis, V. Askiti et al., “Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European paediatric dialysis working group,” Nephrology Dialysis Transplantation, vol. 28, no. 7, pp. 1908–1914, 2013. View at Publisher · View at Google Scholar
  78. M. Honda and B. A. Warady, “Long-term peritoneal dialysis and encapsulating peritoneal sclerosis in children,” Pediatric Nephrology, vol. 25, no. 1, pp. 75–81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. A. K. Bayazit, B. A. Vogt, K. M. Dell et al., “Effect of the peritoneal dialysis prescription on pentosidine in children,” Pediatric Nephrology, vol. 18, no. 10, pp. 1049–1054, 2003. View at Publisher · View at Google Scholar · View at Scopus
  80. T. Hölttä, K. Rönnholm, H. Jalanko, and C. Holmberg, “Clinical outcome of pediatric patients on peritoneal dialysis under adequacy control,” Pediatric Nephrology, vol. 14, no. 10-11, pp. 889–897, 2000. View at Google Scholar · View at Scopus
  81. J. H. van der Voort, E. A. Harvey, B. Braj, and D. F. Geary, “Can the DOQI guidelines be met by peritoneal dialysis alone in pediatric patients?” Pediatric Nephrology, vol. 14, no. 8-9, pp. 717–719, 2000. View at Google Scholar · View at Scopus
  82. S. A. Bakkaloǧlu, F. Yalçinkaya, N. Tümer, M. Ekim, and A. H. Elhan, “Impact of residual renal function on dialysis adequacy in paediatric CAPD patients,” International Urology and Nephrology, vol. 31, no. 6, pp. 821–826, 1999. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Boehm, A. Vácsei, C. Aufricht, T. Mueller, D. Csaicsich, and K. Arbeiter, “Risk factors for peritonitis in pediatric peritoneal dialysis: a single-center study,” Pediatric Nephrology, vol. 20, no. 10, pp. 1478–1483, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. G. Montini, G. Amici, S. Milan et al., “Middle molecule and small protein removal in children on peritoneal dialysis,” Kidney International, vol. 61, no. 3, pp. 1153–1159, 2002. View at Publisher · View at Google Scholar · View at Scopus
  85. F. Schaefer, G. Klaus, and O. Mehls, “Peritoneal transport properties and dialysis dose affect growth and nutritional status in children on chronic peritoneal dialysis,” Journal of the American Society of Nephrology, vol. 10, no. 8, pp. 1786–1792, 1999. View at Google Scholar · View at Scopus
  86. V. Chadha, D. L. Blowey, and B. A. Waraby, “Is growth a valid outcome measure of dialysis clearance in children undergoing peritoneal dialysis?” Peritoneal Dialysis International, vol. 21, supplement 3, pp. S179–S184, 2001. View at Google Scholar · View at Scopus
  87. D. Borzych, L. Rees, I. S. Ha et al., “The bone and mineral disorder of children undergoing chronic peritoneal dialysis,” Kidney International, vol. 78, no. 12, pp. 1295–1304, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. “KDOQI clinical practice guideline for nutrition in children with CKD: 2008 update,” The American Journal of Kidney Diseases, vol. 53, supplement 2, pp. 1–123, 2009.
  89. F. J. Cano, V. S. Marín, M. A. Azocar et al., “Adequacy and nutrition in pediatric peritoneal dialysis,” Advances in Peritoneal Dialysis, vol. 19, pp. 273–278, 2003. View at Google Scholar · View at Scopus
  90. F. J. Cano, M. A. Azocar, M. A. Delucchi et al., “Nitrogen balance studies and Kt/V urea in children undergoing chronic peritoneal dialysis,” Advances in Peritoneal Dialysis, vol. 20, pp. 245–250, 2004. View at Google Scholar · View at Scopus
  91. A. Edefonti, F. Paglialonga, M. Picca et al., “A prospective multicentre study of the nutritional status in children on chronic peritoneal dialysis,” Nephrology Dialysis Transplantation, vol. 21, no. 7, pp. 1946–1951, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. B. Acar, F. Yalçinkaya, N. Çakar et al., “The outcome for pediatric patients on peritoneal dialysis,” Journal of Nephrology, vol. 21, no. 3, pp. 394–399, 2008. View at Google Scholar · View at Scopus
  93. S. R. Mendley and N. L. Majkowski, “Urea and nitrogen excretion in pediatric peritoneal dialysis patients,” Kidney International, vol. 58, no. 6, pp. 2564–2570, 2000. View at Publisher · View at Google Scholar · View at Scopus
  94. J. W. Groothoff, M. P. Gruppen, M. Offringa et al., “Mortality and causes of death of end-stage renal disease in children: a dutch cohort study,” Kidney International, vol. 61, no. 2, pp. 621–629, 2002. View at Publisher · View at Google Scholar · View at Scopus
  95. R. S. Parekh, C. E. Carroll, R. A. Wolfe, and F. K. Port, “Cardiovascular mortality in children and young adults with end-stage kidney disease,” Journal of Pediatrics, vol. 141, no. 2, pp. 191–197, 2002. View at Publisher · View at Google Scholar · View at Scopus
  96. M. Tkaczyk, M. Nowicki, I. Bałasz-Chmielewska et al., “Hypertension in dialysed children: the prevalence and therapeutic approach in Poland—a nationwide survey,” Nephrology Dialysis Transplantation, vol. 21, no. 3, pp. 736–742, 2006. View at Publisher · View at Google Scholar · View at Scopus
  97. S. A. Bakkaloglu, A. Saygili, L. Sever et al., “Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish pediatric peritoneal dialysis study group (TUPEPD) report,” Nephrology Dialysis Transplantation, vol. 24, no. 11, pp. 3525–3532, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. D. Borzych-Duzalka, Y. Bilginer, I. S. Ha et al., “Management of anemia in children receiving chronic peritoneal dialysis,” Journal of American Society of Nephrology, vol. 24, no. 4, pp. 665–676, 2013. View at Publisher · View at Google Scholar
  99. H. Y. Cho, H. S. Hyun, H. G. Kang, I. S. Ha, and H. I. Cheong, “Prevalence of 25(OH) vitamin D insufficiency and deficiency in pediatric patients on chronic dialysis,” Peritoneal Dialysis International, vol. 33, no. 4, pp. 398–404, 2013. View at Publisher · View at Google Scholar
  100. C. P. Schmitt, D. von Heyl, S. Rieger et al., “Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content,” Nephrology Dialysis Transplantation, vol. 22, no. 7, pp. 2038–2044, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Roszkowska-Blaim, P. Skrzypczyk, A. Jander et al., “The effect of peritoneal dialysis method on residual renal function in children,” Advances in Peritoneal Dialysis, vol. 28, pp. 112–119, 2012. View at Google Scholar